natgillin/translations-raw huggingface dataset:
There is no need to alter the dose in patients with mild or moderate kidney problems (patients with a creatinine clearance > 30 ml/min). 
Pri bolnikih z blago ali zmerno okvaro ledvic (bolniki z očistkom kreatinina > 30 ml/min) ni treba prilagajati odmerka.
Pharmacokinetics of iloprost were investigated in a randomised, crossover study with 27 patients, stable on Ventavis 10 microgram/ml inhaled with I-Neb, following inhalation of single doses of 2.5 or 5 microgram iloprost using the Breelib or the I-Neb AAD nebuliser. 
Farmakokinetiko iloprosta so preučevali v randomizirani, navzkrižni študiji, v kateri je sodelovalo 27 bolnikov, ki so zdravilo Ventavis 10 mikrogramov/ml inhalirali z nebulatorjem I-Neb in bili stabilni, po inhalaciji enkratnega odmerka 2,5 ali 5 mikrogramov iloprosta z nebulatorjem Breelib ali I-Neb AAD.
Ventavis is a clear, colourless nebuliser solution for inhalation with the Breelib, the I-Neb or the Venta-Neb nebuliser. 
Zdravilo Ventavis je bistra, brezbarvna inhalacijska raztopina za inhaliranje z nebulatorjem Breelib, INeb ali Venta-Neb.
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has also been shown to be suitable for the administration of Ventavis 10 microgram/ml. 
Prenosni, ultrazvočni, baterijski nebulator Venta-Neb je dokazano primeren tudi za apliciranje zdravila Ventavis 10 mikrogramov/ml.
Tetranor-iloprost is pharmacologically inactive as shown in animal experiments. 
Glede na izsledke poskusov na živalih, je tetranor-iloprost farmakološko neaktiven.
Any Ventavis solution remaining in the nebuliser after inhalation must be thrown away. 
Vso raztopino zdravila Ventavis, ki po inhalaciji ostane v nebulatorju, morate zavreči.
• chest discomfort / chest pain 
• neprijeten občutek v prsnem košu/bolečine v prsnem košu
Data with intravenously administered iloprost indicated that the elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis (see section 5.2). 
Podatki o intravenski uporabi iloprosta so pokazali, da je izločanje iloprosta pri bolnikih z okvaro jeter kot tudi pri tistih z okvaro ledvic, ki potrebujejo zdravljenje z dializo, zmanjšano (glejte poglavje 5.2).
Because iloprost is extensively metabolised by the liver, the plasma levels of the active substance are influenced by changes in hepatic function. 
Okvara jeter Ker se iloprost v glavnem presnavlja v jetrih, spremembe v delovanju jeter vplivajo na koncentracije učinkovine v plazmi.
• Bronchospasm (sudden constriction of the muscles in the walls of the small airways) and wheezing (see also section 2 “Warnings and precautions”) 
Neznana (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov) • Bronhospazem (nenaden krč mišic v steni majhnih dihalnih poti) in zasoplost (glejte tudi poglavje 2 »Opozorila in previdnostni ukrepi«).
Your doctor will supervise your treatment when you start using the Breelib nebuliser to ensure that you tolerate dose and speed of inhalation well. 
Ko boste začeli uporabljati nebulator Breelib, bo zdravnik nadzoroval zdravljenje, da se bo prepričal, da dobro prenašate odmerek in hitrost inhaliranja.
One inhalation session will usually last about 4 to 10 minutes with I-Neb AAD depending on the prescribed dose. 
Posamezna inhalacija z nebulatorjem I-Neb ADD traja običajno 4 do 10 minut, odvisno od predpisanega odmerka.
Careful monitoring of the patient should be performed when inhaled iloprost therapy is stopped and an alternative treatment should be considered in critically ill patients. 
Pri prenehanju zdravljenja z inhalacijskim iloprostom je kritično bolne osebe treba skrbno spremljati in uvesti morebitno alternativno zdravljenje.
The measured MMAD of the aerosol droplets was 2.1 micrometres. 
Mediani masni aerodinamični premer (MMAD) kapljic aerosola je bil 2,1 mikrometra.
Interruption of therapy 
Prekinitev zdravljenja
Ampoules with 2 ml nebuliser solution (for the use of Venta-Neb): 
Ampule z 2 ml inhalacijske raztopine za nebulator (za uporabo z nebulatorjem Venta-Neb)
PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML CO-PACKED WITH BREELIB CONSUMABLES SET 
PAKIRANJE Z 42 AMPULAMI V ŠKATLI S 168 (4 X 42) AMPULAMI Z 1 ML PAKIRANJE Z 42 AMPULAMI V ŠKATLI S 168 (4 X 42) AMPULAMI Z 1 ML IN SETOM ZA UPORABO NEBULATORJA BREELIB
If inhalation with Ventavis 10 microgram/ml is well tolerated, the dose should be increased by using Ventavis 20 microgram/ml. 
Če bolnik odmerek zdravila Ventavis 10 mikrogramov/ml dobro prenaša, je treba odmerek povečati z uporabo zdravila Ventavis 20 mikrogramov/ml.
Start therapy by inhaling 2.5 microgram iloprost using 1 ml ampoule of Ventavis 10 microgram/ml (with white and yellow rings). 
Začnite zdravljenje z inhaliranjem 2,5 mikrogramov iloprosta z uporabo 1-mililitrske ampule zdravila Ventavis 10 mikrogramov/ml (z belim in rumenim obročem).
How Ventavis works 
Kako deluje zdravilo Ventavis
Very common (may affect more than 1 in 10 people): 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov)
Ventavis 20 microgram/ml is double the concentration of Ventavis 10 microgram/ml. 
Zdravilo Ventavis 20 mikrogramov/ml je v dvakrat večji koncentraciji glede na zdravilo Ventavis 10 mikrogramov/ml.
What Ventavis is used for 
Za kaj se uporablja zdravilo Ventavis
The pre-set dose provided by the I-Neb AAD nebuliser is controlled by the medication chamber in combination with a control disc. 
Predhodno določen odmerek, ki ga dovaja nebulator I-Neb AAD, je nadzorovan s prostorom za zdravilo in nadzornim diskom.
Blood pressure should be checked while initiating Ventavis. 
Med uvajanjem zdravila Ventavis je treba nadzorovati krvni tlak.
Breelib is a small handheld, battery-powered, breath activated, vibrating mesh technology system. 
Breelib je majhen ročni baterijski pripomoček za razprševanje, ki se aktivira ob inhalaciji in katerega delovanje temelji na tehnologiji vibrirajoče mrežice.
Ventavis is a clear, colourless to slightly yellowish nebuliser solution for inhalation with the Breelib or the I-Neb nebuliser. 
Zdravilo Ventavis je bistra, brezbarvna do rahlo rumenkasta inhalacijska raztopina za uporabo z nebulatorjem Breelib ali I-Neb.
Each ml contains 1.62 mg ethanol 96% (equivalent to 1.50 mg ethanol). 
• Ventavis 20 mikrogramov/ml 1 ml raztopine vsebuje 1,62 mg 96-odstotnega etanola (kar ustreza 1,50 mg etanola).
The table below provides a summary of the user instructions of the I-Neb: 
V spodnji preglednici je predstavljen povzetek navodil za uporabo nebulatorja I-Neb.
The ampoules containing 1 ml are marked with two coloured rings (yellow-red). 
Ampule, ki vsebujejo 1 ml raztopine, so označene z dvema barvnima obročema (rumen-rdeč).
Food or drink is not expected to affect Ventavis. 
Ni pričakovati, da bi hrana ali pijača vplivali na zdravilo Ventavis, kljub temu pa se med vdihavanjem izogibajte hrani in pijači.
Hydrochloric acid (for pH adjustment) Water for injections 
96-odstotni etanol natrijev klorid klorovodikova kislina (za uravnavanje vrednosti pH) voda za injekcije
PACK WITH 30 AMPOULES IN A CARTON WITH 90 (3 x 30) AMPOULES WITH 2 ML PACK WITH 30 AMPOULES IN A CARTON WITH 300 (10 x 30) AMPOULES WITH 2 ML 
NOTRANJA ŠKATLA BREZ MODREGA OKENCA PAKIRANJE S 30 AMPULAMI V ŠKATLI Z 90 (3 X 30) AMPULAMI Z 2 ML PAKIRANJE S 30 AMPULAMI V ŠKATLI S 300 (10 X 30) AMPULAMI Z 2 ML
“How to use Ventavis”). 
Ventavis«).
Using more Ventavis than you should may lead to dizziness, headache, flushing (reddening of the face), nausea (feeling sick), jaw pain or back pain. 
Če ste uporabili večji odmerek zdravila Ventavis, kot bi smeli Če uporabite večji odmerek zdravila Ventavis, kot bi smeli, se lahko pojavijo omotica, glavobol, pordelost (rdečica obraza), navzea (občutek siljenja na bruhanje), bolečine v čeljustih ali bolečine v hrbtu.
Ampoules with 1 ml nebuliser solution (for the use of Breelib or I-Neb AAD): 
Ampule z 1 ml inhalacijske raztopine za nebulator (za uporabo z nebulatorjem Breelib ali I-Neb AAD)
In case of poor tolerability of Ventavis 20 microgram/ml, the dose should be reduced by using 1 ml ampoule of Ventavis 10 microgram/ml (see section 4.4). 
Če bolnik slabo prenaša zdravilo Ventavis 20 mikrogramov/ml, je treba odmerek zmanjšati z uporabo 1 ml ampule zdravila Ventavis 10 mikrogramov/ml (glejte poglavje 4.4).
168 (4 x 42) AMPOULES WITH 1 ML 
168 (4 x 42) AMPUL Z 1 ML
For details refer to the instruction manual of the Venta-Neb nebuliser. 
Za podrobnosti glejte navodila za uporabo nebulatorja Venta-Neb.
5 mcg 
5 mikrogramov
The I-Neb AAD System is a portable, hand-held, vibrating mesh technology nebuliser system. 
Nebulator I-Neb AAD je prenosni, ročni pripomoček za razprševanje, ki temelji na tehnologiji vibrirajoče mrežice.
Each ml contains 0.81 mg ethanol 96% (equivalent to 0.75 mg ethanol) 
• Ventavis 10 mikrogramov/ml 1 ml raztopine vsebuje 0,81 mg 96-odstotnega etanola (kar ustreza 0,75 mg etanola).
At initiation of Ventavis treatment or if the patient is switched from an alternative device, the first inhalation should be made with 1 ml ampoule of Ventavis 10 microgram/ml (see section 4.4). 
Ob uvedbi zdravljenja z zdravilom Ventavis ali ob prehodu bolnika na drug pripomoček je treba prvi vpih izvesti z 1 ml ampulo zdravila Ventavis 10 mikrogramov/ml (glejte poglavje 4.4).
This nebuliser monitors the breathing pattern to determine the aerosol pulse time required to deliver the pre-set dose of 2.5 or 5 microgram iloprost. 
Nebulator spremlja način dihanja in tako določi pulzni čas aerosola, potreben za dovajanje nastavljenega odmerka 2,5 ali 5 mikrogramov iloprosta.
This nebuliser monitors the breathing pattern to determine the aerosol pulse time required to deliver the pre-set dose of 5 microgram iloprost. 
Nebulator spremlja način dihanja in tako določi pulzni čas aerosola, potreben za dovajanje predhodno nastavljenega odmerka 5 mikrogramov iloprosta.
Diarrhoea Vomiting Mouth and tongue irritation including pain 
Bolezni prebavil navzea driska bruhanje draženje v ustih in draženje jezika, tudi bolečina disgevzija
Peripheral oedema is a very common symptom of the disease itself, but can also occur under therapy. 
Periferni edem je zelo pogost simptom same bolezni, lahko pa se pojavi tudi med zdravljenjem.
Syncope is a common symptom of the disease itself and can also occur under therapy. 
Sinkopa je pogost simptom bolezni same in se lahko pojavi tudi med zdravljenjem.
The haemodynamics observed suggest an acute response with preferential effect of inhaled treatment on the pulmonary vessels. 
Opazovani akutni hemodinamični odziv kaže, da je učinek na pljučno žilje po inhaliranju boljši.
Syncope is a common symptom of the disease itself, but can also occur under therapy. 
Sinkopa je pogost simptom same bolezni, lahko pa se pojavi tudi med zdravljenjem.
Since the I-Neb AAD nebuliser can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis: 
Ker se lahko nebulator I-Neb AAD uporablja za zdravilo Ventavis 10 mikrogramov/ml in zdravilo Ventavis 20 mikrogramov/ml, je v naslednji preglednici povzetek navodil za uporabo nebulatorja I-Neb za dve koncentraciji zdravila Ventavis.
Musculoskeletal and connective tissue disorders 
Bolezni mišičnoskeletnega in vezivnega tkiva bolečine v čeljusti /
For administration with the Breelib. 
Za uporabo z nebulatorjem Breelib.
Patients stabilised on one nebuliser should not switch to another nebuliser without close supervision by the treating doctor as different nebulisers have been shown to produce aerosols with slightly different physical characteristics and may have faster delivery of the solution (see section 5.2 of the Summary of Product Characteristics). 
če tega skrbno ne nadzoruje lečeči zdravnik, saj se je pokazalo, da različni nebulatorji ustvarjajo aerosole z nekoliko drugačnimi fizikalnimi lastnostmi in lahko hitreje dovajajo raztopino (glejte poglavje 5.2 Povzetka glavnih značilnosti zdravila).
When iloprost at the concentration of 10 microgram/ml is administered via inhalation in patients with pulmonary hypertension or healthy volunteers (iloprost dose at the mouthpiece: 5 microgram: inhalation time in between 4.6 - 10.6 min), mean peak serum concentrations of about 100 to 200 picogram/ml were observed at the end of inhalation session. 
Po inhaliranju iloprosta v koncentraciji 10 mikrogramov/ml pri bolnikih s pljučno hipertenzijo ali zdravih prostovoljcih (odmerek iloprosta v ustniku: 5 mikrogramov: inhalacijski čas je med 4,6 in
6.5 Nature and contents of container Ventavis 10 microgram/ml nebuliser solution 
6.5 Vrsta ovojnine in vsebina Ventavis 10 mikrogramov/ml inhalacijska raztopina za nebulator
In case of poor tolerability of the 5 microgram dose, the dose should be reduced to 2.5 microgram iloprost. 
Če bolnik odmerek 5 mikrogramov slabo prenaša, je treba odmerek zmanjšati na 2,5 mikrogramov iloprosta.
To obtain the optimal droplet size for the administration of Ventavis the green baffle plate should be used. 
Da bi dosegli optimalno velikost kapljic za aplikacijo zdravila Ventavis, je treba uporabiti zeleno ploščo.
The I-Neb AAD nebuliser has been shown to be suitable for the administration of Ventavis 10 microgram/ml (1 ml ampoule) and 20 microgram/ml nebuliser solution. 
Pokazali so, da je nebulator I-Neb AAD primeren za dovajanje zdravila Ventavis 10 mikrogramov/ml (1 ml ampula) in 20 mikrogramov/ml inhalacijska raztopina za nebulator.
• Breelib nebuliser 
• Nebulator Breelib
Iloprost may increase the effects of vasodilatators and antihypertensive agents and then favour the risk of hypotension (see section 4.4). 
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Iloprost lahko poveča učinek vazodilatatorjev in antihipertenzivov in tako poveča tveganje za pojav hipotenzije (glejte poglavje 4.4).
Ventavis 10 microgram/ml is provided in colourless ampoules, containing either 1 ml or 2 ml nebuliser solution. 
Zdravilo Ventavis 10 mikrogramov/ml je na voljo v brezbarvnih ampulah, ki vsebujejo 1 ml ali 2 ml inhalacijske raztopine za nebulator.
To minimise accidental exposure, it is recommended to keep the room well ventilated. 
Za zmanjšanje nenamerne izpostavljenosti je priporočljivo dobro zračenje prostora.
• pain in jaw/spasm of the jaw muscles (trismus) 
• bolečina v čeljusti/krč čeljustnih mišic (trizmus)
Ventavis therapy should only be initiated by a physician experienced in treatment of pulmonary hypertension. 
Kako uporabljati zdravilo Ventavis Zdravljenje z zdravilom Ventavis lahko uvede le zdravnik z izkušnjami z zdravljenjem pljučne hipertenzije.
Thereafter, dosing intervals may be shortened cautiously based on individual tolerability. 
Kasneje se lahko intervale med posameznimi odmerki previdno krajša glede na to, kako bolnik prenaša zdravilo.
The use of Ventavis is not recommended in patients with unstable pulmonary hypertension, with advanced right heart failure. 
Pri bolnikih z nestabilno pljučno hipertenzijo ter napredujočim desnostranskim srčnim popuščanjem se uporabe zdravila Ventavis ne priporoča.
For patients being switched from an alternative device to the Breelib nebuliser the first inhalation should be made with Ventavis 10 microgram/ml (1ml ampoule) delivering 2.5 microgram iloprost at the mouthpiece and under close medical supervision to ensure that the faster inhalation provided by Breelib is well tolerated. 
Pri bolnikih, ki so z drugega nebulatorja prešli na nebulator Breelib, je treba pod skrbnim zdravniškim nadzorom za prvo inhaliranje uporabiti zdravilo Ventavis 10 mikrogramov/ml (1 ml ampula), ki skozi ustnik dovaja 2,5 mikrograma iloprosta in se prepričati, da bolnik hitrejše inhaliranje, ki ga omogoča nebulator Breelib, dobro prenaša.
1 ml solution contains 10 microgram iloprost (as iloprost trometamol). 
1 ml raztopine vsebuje 10 mikrogramov iloprosta (v obliki trometamolijevega iloprostata).
Ventavis should only be initiated and monitored by a physician experienced in the treatment of pulmonary hypertension. 
I-Neb AAD Zdravljenje z zdravilom Ventavis lahko uvede in spremlja le zdravnik, ki ima izkušnje z zdravljenjem pljučne hipertenzije.
Just before you start to inhale, break the glass ampoule containing 2 ml solution, which has two coloured rings (white-pink), and pour the complete contents into the nebuliser medication chamber. 
Tik pred začetkom inhaliranja prelomite stekleno ampulo, ki vsebuje 2 ml raztopine in je označena z dvema barvnima obročema (bel-rožnat) in celotno vsebino zlijte v prostor za zdravilo v nebulatorju.
1 ml solution contains 20 microgram iloprost (as iloprost trometamol). 
1 ml raztopine vsebuje 20 mikrogramov iloprosta (v obliki trometamolijevega iloprostata).
2.5 microgram 5 microgram 
2,5 mikrograma 5 mikrogramov
• For the 2.5 microgram dose the medication chamber with the red coloured latch is used together with the red control disc. 
• Za odmerek 2,5 mikrogramov se uporablja prostor za zdravilo z rdečim zapahom in rdečim nadzornim diskom.
Different nebuliser devices can be used to administer Ventavis. 
Za dovajanje zdravila Ventavis se lahko uporabljajo različni nebulatorji.
Ventavis 20 microgram/ml is provided in colourless ampoules, containing 1 ml nebuliser solution. 
Zdravilo Ventavis 20 mikrogramov/ml je na voljo v brezbarvnih ampulah, ki vsebujejo 1 ml inhalacijske raztopine za nebulator.
In the iloprost group, the median daily inhaled dose was 30 microgram (range 12.5 to 45 microgram/day). 
V skupini, ki je prejemala iloprost, je bil mediani dnevni inhalirani odmerek 30 mikrogramov (razpon od
Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule) delivers 2.5 microgram and Ventavis 20 microgram/ml nebuliser solution delivers 5 microgram at the mouthpiece of the Breelib nebuliser. 
Zdravilo Ventavis 10 mikrogramov/ml inhalacijska raztopina za nebulator (1 ml ampula) dovede 2,5 mikrogramov in zdravilo Ventavis 20 mikrogramov/ml inhalacijska raztopina za nebulator dovede 5 mikrogramov skozi ustnik nebulatorja Breelib.
85 mmHg for the upper value) then therapy with Ventavis should not be started. 
Pred zdravljenjem vam bodo izmerili krvni tlak in če je ta prenizek (zgornja vrednost je nižja od 85 mmHg), se zdravljenja z zdravilom Ventavis ne sme začeti.
If this dose is well tolerated, dosing should be increased to 5 microgram iloprost and maintained at that dose. 
Če bolnik ta odmerek dobro prenaša, je treba odmerek povečati na 5 mikrogramov iloprosta in ga vzdrževati.
If you tolerate this dose well, your dose should be increased to 5 microgram iloprost and you should continue on this dose. 
Če ta odmerek dobro prenašate, je treba odmerek povečati na 5 mikrogramov iloprosta in s tem odmerkom nadaljevati.
A mean increase in the 6-minute walk test of 44.7 metres from a baseline mean value of 329 metres vs. a change of -7.4 metres from a baseline mean value of 324 metres in the placebo group (no data imputation for death or missing values) was observed in the subgroup of 49 patients with primary pulmonary hypertension receiving treatment of inhaled iloprost for 12 weeks (46 patients in the placebo group). 
V podskupini 49 bolnikov s primarno pljučno hipertenzijo, ki so 12 tednov prejemali inhalacije iloprosta (46 bolnikov v placebo skupini), je bila v 6-minutnem testu hoje povprečno podaljšanje prehojene razdalje 44,7 metrov glede na povprečno izhodiščno razdaljo 329 metrov, v placebo skupini pa je bila ta razlika -7,4 metrov od povprečne izhodiščne razdalje 324 metrov (vključeni niso podatki o smrtih ali manjkajočih vrednostih).
Part of a multipack containing 168 (4 x 42) ampoules with 1 ml. 
Del škatle večkratnega pakiranja, ki vsebuje 168 (4 x 42) ampul z 1 ml.
Multipack: 300 (10 x 30) ampoules with 2 ml. 
Večkratno pakiranje: 300 (10 x 30) ampul z 2 ml
For the 2.5 microgram dose of Ventavis 10 microgram/ml the medication chamber with the red coloured latch is used together with the red control disc. 
Za odmerek 2,5 mikrogramov zdravila Ventavis 10 mikrogramov/ml se uporablja prostor za zdravilo z rdečim zapahom in rdečim nadzornim diskom.
Patients stabilised on one nebuliser should not switch to another nebuliser without supervision by the treating physician as different nebulisers have been shown to produce aerosols with slightly different physical characteristics and delivery of the solution that may be faster (see section 5.2). 
če tega ne nadzoruje lečeči zdravnik, saj se je pokazalo, da različni nebulatorji ustvarjajo aerosole z nekoliko drugačnimi fizikalnimi lastnostmi in lahko hitreje dovajajo raztopine (glejte poglavje 5.2).
Venta-Neb, a portable ultrasonic battery-powered nebuliser, has been shown to be suitable for the administration of Ventavis 10 microgram/ml nebuliser solution (2 ml ampoule). 
Prenosni, ultrazvočni, baterijski nebulator Venta-Neb je dokazano primeren tudi za apliciranje zdravila Ventavis 10 mikrogramov/ml inhalacijska raztopina za nebulator (2 ml ampula).
The Mass Median Aerodynamic Diameter (MMAD) of the aerosol is between 1 and 5 micrometers. 
(MMAD) aerosola je med 1 in 5 mikrometrov.
If you are starting Ventavis treatment or if you switch from an alternative device your first inhalation will be with Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings). 
Če začnete zdravljenje z zdravilom Ventavis ali preidete z drugega pripomočka na nebulator Breelib, boste najprej inhalirali zdravilo Ventavis 10 mikrogramov/ml (1-mililitrska ampula z belim in rumenim obročem).
30 AMPOULES WITH 1 ML 
30 AMPUL Z 1 ML
Breelib nebuliser: 
Nebulator Breelib
Ventavis 20 microgram/ml nebuliser solution 5 years. 
Ventavis 20 mikrogramov/ml inhalacijska raztopina za nebulator 5 let
For Ventavis 20 microgram/ml (5 microgram dose), the medication chamber with the golden coloured latch is used together with the golden control disc. 
Za zdravilo Ventavis 20 mikrogramov/ml (odmerek 5 mikrogramov) se uporablja prostor za zdravilo z zlatim zapahom in zlatim nadzornim diskom.
Ventavis 10 microgram/ml (1 ml ampoule) and Ventavis 20 microgram/ml nebuliser solution 
Ventavis 10 mikrogramov/ml (1 ml ampula) in Ventavis 20 mikrogramov/ml inhalacijska raztopina za nebulator
EU/1/03/255/013 [168 (4 x 42) x 1 ml] co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber). 
EU/1/03/255/013 [168 (4 x 42) x 1 ml] in set za uporabo nebulatorja Breelib (1 ustnik in 1 prostor za zdravilo).
EU/1/03/255/014 [168 (4 x 42) x 1 ml] co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber). 
EU/1/03/255/014 [168 (4 x 42) x 1 ml] in set za uporabo nebulatorja Breelib (1 ustnik in 1 prostor za zdravilo).
Your doctor will supervise your treatment if switching from Ventavis 10 microgram /ml to Ventavis 20 microgram/ml to monitor how well you tolerate the higher concentration. 
Ventavis 10 mikrogramov/ml na zdravilo Ventavis 20 mikrogram/ml bo zdravnik nadzoroval, kako dobro prenašate zdravilo z večjo koncentracijo.
Initially, doses of 2.5 microgram iloprost should be administered using Ventavis 10 microgram/ml with dosing intervals of 3-4 hours (corresponds to administration of max. 6 times per day). 
Ob uvedbi zdravljenja mora med biti interval med posameznimi 2,5-mikrogramskimi odmerki iloprosta v zdravilu Ventavis 10 mikorgramov/ml 3 - 4 ure (kar ustreza največ 6 aplikacijam na dan).
This system generates droplets by ultrasound, which forces the solution through a mesh. 
Nebulatorski sistem s pomočjo ultrazvoka potiska raztopino skozi mrežico in tako ustvarja kapljice.
Multipack: 90 (3 x 30) ampoules with 2 ml. 
Večkratno pakiranje: 90 (3 x 30) ampul z 2 ml
Other people might accidentally be exposed to Ventavis through the room air. 
Zaradi neustreznega zračenja lahko pride do naključne izpostavljenosti drugih oseb zdravilu Ventavis.
Be sure to ventilate or air the room in which you have taken your Ventavis treatment. 
Poskrbite, da bo prostor, v katerem ste inhalirali zdravilo Ventavis, ustrezno ventiliran oziroma prezračen.
Dose of iloprost at mouthpiece 
Odmerek iloprosta v ustniku
30 ampoules with 2 ml. 
30 ampul z 2 ml.